Sanofi, Regeneron expand immunology alliance with $1 billion upfront payment
AI Summary- Sanofi and Regeneron expanded their immunology drug alliance with four new candidates.
- Regeneron will receive $1 billion upfront and may earn up to $7 billion in milestones.
- The companies settled prior collaboration litigation and retained existing Dupixent profit-sharing terms.